Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01745211 · ClinicalTrials.gov registry record · NA
755nm Alex Laser for Treatment of Stretch Marks
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01745211: Completed NA study, sponsored by Cynosure.
NCT01745211 is a NA study that has completed, run by Cynosure. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01745211, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of the bilateral treatment of striae using a 755nm Alexandrite laser.
Primary Outcome
The physician will judge the overall improvement by selecting from improvement ranges of 0-25%, 25-50%, 50-75%, or 75-100% clearance when compared to the baseline.
Interventions
- DEVICE 755nm Alexandrite Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT01745211 record still lists
NCT01745211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which 755nm Alexandrite Laser is the first listed.
NCT01745211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01745211 about?
NCT01745211 is a clinical study titled "755nm Alex Laser for Treatment of Stretch Marks". Evaluate the safety and efficacy of the bilateral treatment of striae using a 755nm Alexandrite laser.
What is the current status of trial NCT01745211?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2012-01. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01745211?
The interventions under investigation include: 755nm Alexandrite Laser (DEVICE).
Who is sponsoring clinical trial NCT01745211?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01745211's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia